Libya vs Saint Vincent and the Grenadines: Tuberculosis treatment success rate in new and relapsed cases
Libya
57
in 2023
Saint Vincent and the Grenadines
60
in 2022
Libya rank
186th
Saint Vincent and the Grenadines rank
183rd
Tuberculosis treatment success rate in new and relapsed cases over time
- Libya
- Saint Vincent and the Grenadines
How they compare
Saint Vincent and the Grenadines currently reports 60 against 57 in Libya, a difference of 3.
That makes Saint Vincent and the Grenadines's figure about 1.1 times Libya's.
The two have swapped places 8 times across 13 shared years of data; in 1999 it was Saint Vincent and the Grenadines ahead.
Libya ranks 186th and Saint Vincent and the Grenadines ranks 183rd of 206 countries.
Across the 4 decades both report, Libya averaged higher in 2 and Saint Vincent and the Grenadines in 2.
Head to head by decade
| Decade | Libya | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 67 | 88 | 21 | Saint Vincent and the Grenadines |
| 2000s | 70.33 | 78 | 7.67 | Saint Vincent and the Grenadines |
| 2010s | 62.83 | 51.33 | 11.5 | Libya |
| 2020s | 63.67 | 55.33 | 8.33 | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate in new and relapsed cases, Libya or Saint Vincent and the Grenadines?
- Saint Vincent and the Grenadines, at 60 against 57 in Libya as of 2022.
- What is the difference in tuberculosis treatment success rate in new and relapsed cases between Libya and Saint Vincent and the Grenadines?
- 3, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Libya and Saint Vincent and the Grenadines?
- 13 years are reported by both, from 1999 to 2022.
- How do Libya and Saint Vincent and the Grenadines rank globally for tuberculosis treatment success rate in new and relapsed cases?
- Libya ranks 186th and Saint Vincent and the Grenadines ranks 183rd of 206 countries.
- Where does this data come from?
- Our World in Data, published as Tuberculosis treatment success rate in new and relapsed cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.